Beta Bionics, Inc. (NasdaqGM: BBNX)
Health Care · Health Care Equipment & Supplies · US
$19.05
-2.21% today · +12.8% 1Y
Beta Bionics, Inc. (NasdaqGM: BBNX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $857.05M and employs 422 people.
Over the last twelve months the share price has gained 12.8%, trading between 8.80 and 32.71.
Tweenvest scores Beta Bionics, Inc. across four factors: quality 34/100, value 62/100. Its strongest factor is value.
BBNX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $857.05M
- Revenue (TTM)
- $119.01M
- P/E
- —
- EPS
- -1.65
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $32.71
- 52-week low
- $8.80
- Avg volume (3M)
- —
- Shares outstanding
- 44.99M
- Employees
- 422
- Next earnings
- —
About Beta Bionics, Inc.
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
- Founded
- 2015
- Listed since
- Jan 30, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.